Marshall Wace
LFST icon

Marshall Wace’s Lifestance Health LFST Stock Holding History

Marshall Wace’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4M Buy
1,627,266
+1,389,339
+584% +$10.7M 0.01% 784
2026
Q1 		$1.52M Sell
237,927
-100,831
-30% -$702K ﹤0.01% 1934
2025
Q4 		$2.38M Sell
338,758
-1,049,866
-76% -$6.34M ﹤0.01% 1496
2025
Q3 		$7.64M Buy
+1,388,624
New +$6.8M 0.01% 1023
2025
Q2 		– Sell
-887,192
Closed -$5.91M – 2955
2025
Q1 		$5.91M Buy
887,192
+531,268
+149% +$4.04M 0.01% 985
2024
Q4 		$2.62M Buy
+355,924
New +$2.55M ﹤0.01% 1332
2024
Q2 		– Sell
-122,243
Closed -$754K – 2761
2024
Q1 		$754K Buy
+122,243
New +$823K ﹤0.01% 1768
2023
Q4 		– Sell
-73,766
Closed -$507K – 2422
2023
Q3 		$507K Buy
+73,766
New +$598K ﹤0.01% 1722
2023
Q2 		– Sell
-295,108
Closed -$2.19M – 2734
2023
Q1 		$2.19M Buy
+295,108
New +$1.64M ﹤0.01% 1409
2022
Q4 		– Sell
-17,231
Closed -$114K – 3191
2022
Q3 		$114K Buy
+17,231
New +$120K ﹤0.01% 3174

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Marshall Wace's LFST Position: Q2 2026 in Review

Marshall Wace increased its Lifestance Health (LFST) stake by 584% in Q2 2026, buying an estimated $10.7M and bringing the position to 1,627,266 shares worth $17.4M. The position accounts for 0.01% of the portfolio, ranked #784.

Marshall Wace first reported a position in LFST in Q3 2022 and has held it in 10 quarters since. 289 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Marshall Wace held 1,627,266 shares of Lifestance Health worth $17.4M as of Q2 2026.
  • Marshall Wace bought 1,389,339 Lifestance Health shares in Q2 2026, an estimated $10.7M.
  • Lifestance Health made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #784 holding.
  • Marshall Wace first reported a position in Lifestance Health in Q3 2022 and has held it in 10 quarters since.
  • 289 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.